Boris Freidlin

20PUBLICATIONS
32CO-AUTHORS
Stochastic analysis and modellingLiquid biopsiesCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Jan 03, 2026
A note on rank-preserving structural failure time models to account for crossover.

Pedro A Torres-Saavedra, Boris Freidlin, Jong-Hyeon Jeong

|Jan 16, 2025
Evaluating the impact of stratification on the power and cross-arm balance of randomized phase 2 clinical trials.

Anna Moseley, Michael LeBlanc, Boris Freidlin

|Jan 06, 2025
Accrual Suspensions in Seamless Phase II/III Trials: A Review of NRG Oncology Trials.

Chen Hu, Boris Freidlin, Edward L Korn

|Oct 28, 2024
Phase III Evaluation of Treatment Combinations in Three-Arm Trials.

Edward L Korn, Carmen J Allegra, Boris Freidlin

|Jul 10, 2024
Two-to-One Randomization: Rarely Advisable.

Boris Freidlin, Edward L Korn

|May 17, 2024
Avoiding Delays in Reporting Time-to-Event Randomized Trials: Calendar Backstops and Other Approaches.

Megan Othus, Boris Freidlin, Edward L Korn

Pageof 4

Frequent Collaborators

13 joint publications

Edward L Korn

2 joint publications

Chen Hu

2 joint publications

Megan Othus

1 joint publications

Patricia M LoRusso